Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment

NACompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

May 27, 2015

Primary Completion Date

November 9, 2016

Study Completion Date

December 12, 2017

Conditions
Upper Aerodigestive Tract NeoplasmsLung Cancer
Interventions
PROCEDURE

integrated addiction treatment program

"At the inclusion, a 45 min interview for : the completion of questionnaires (Fagerström, AUDIT, CAST, Socrates, M.I.N.I), the collection of socio-professional information, obstacles and incentives to stop the consumption of alcohol and tobacco, the record of alcohol-tobacco consumptions, the measurement of exhaled carbone monoxide rate expressed in particles per million using the CO tester.~At 3, 6, and 12 months : a 20 min interview to assess the alcohol-tobacco consumption and the obstacles and incentives to stop the consumption.~The first addiction consultation will be carried out directly in the cancer treatment unit and integrated to the overall cancer treatment program."

PROCEDURE

standard of care

"The following actions will be performed by a nurse or by the study coordinator on site who have been trained in tobaccology and addictology :~* At the inclusion, a 45 minutes interview for : the completion of questionnaires (Fagerström, AUDIT, CAST, Socrates, M.I.N.I) , the collection of socio-professional information, obstacles and incentives to stop the consumption of alcohol and tobacco, the record of alcohol-tobacco consumptions, the measurement of exhaled carbone monoxide rate expressed in particles per million (ppm) using the CO tester.~* At 3, 6, and 12 months: a 20 minutes interview to assess the alcohol-tobacco consumption and the obstacles and incentives to stop the consumption"

Trial Locations (3)

59020

Oscar Lambret Center, Lille

59037

CHRU of Lille : Albert Calmette Hospital, Lille

CHRU of Lille: Huriez Hospital, Lille

All Listed Sponsors
collaborator

Centre Régional de Référence en Cancérologie

OTHER

collaborator

National Cancer Institute, France

OTHER_GOV

lead

Centre Oscar Lambret

OTHER

NCT02540174 - Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment | Biotech Hunter | Biotech Hunter